SpringWorks reports collaborations re nirogacestat
SpringWorks Therapeutics has entered into a clinical trial collaboration agreement with Precision Biosciences. Per the agreement, PBCAR269A, Precision BioSciences’ wholly-owned investigational allogeneic chimeric antigen receptor T...